Merck Outlines Vioxx Defense

Merck Outlines Vioxx Defense
At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on by the withdrawal of Vioxx, an arthritis pill taken at one time or another by 20 million Americans.


Leave a Reply

Your email address will not be published. Required fields are marked *

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Subscribe!